Literature DB >> 21739227

Use and indications of cholestyramine and bile acid sequestrants.

Franco Scaldaferri1, Marco Pizzoferrato, Francesca Romana Ponziani, Giovanni Gasbarrini, Antonio Gasbarrini.   

Abstract

Cholestyramine is a bile acid sequestrant, like colestipol and colesevelam. These molecules are positively charged non-digestible resins that bind to bile acids in the intestine to form an insoluble complex, which is excreted in the feces. They are used mainly for the treatment of primary hypercholesterolemia and hypercholesterolemia associated with mild hypertriglyceridemia, in patients not responding to dietary treatment as well as a second line-treatment for pruritus associated with cholestatic disease, in patients with incomplete biliary obstruction. Several data indicate that modulation of bile acid homeostasis has a good clinical effect in managing diabetes mellitus and the diarrhea from bile acid malabsorption. In this review, we present the "in label" use and indication for these compounds, revisiting the other clinical applications that may benefit from the use of bile acid sequestrants in the near future.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739227     DOI: 10.1007/s11739-011-0653-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  49 in total

1.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

Review 2.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

3.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte Op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina; Alex Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Christian Funck-Brentano; Gerasimos Filippatos; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jóse Luis Zamorano; Attila Altiner; Enzo Bonora; Paul N Durrington; Robert Fagard; Simona Giampaoli; Harry Hemingway; Jan Hakansson; Sverre Erik Kjeldsen; Mogens Lytken Larsen; Giuseppe Mancia; Athanasios J Manolis; Kristina Orth-Gomer; Terje Pedersen; Mike Rayner; Lars Ryden; Mario Sammut; Neil Schneiderman; Anton F Stalenhoef; Lale Tokgözoglu; Olov Wiklund; Antonis Zampelas
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-09

Review 4.  Evidence-based management of statin myopathy.

Authors:  Charles R Harper; Terry A Jacobson
Journal:  Curr Atheroscler Rep       Date:  2010-09       Impact factor: 5.113

5.  Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.

Authors:  A F Hofmann; J R Poley
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

6.  The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Edith M M Kuiper; Karel J van Erpecum; Ulrich Beuers; Bettina E Hansen; H Bing Thio; Robert A de Man; Harry L A Janssen; Henk R van Buuren
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

7.  Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.

Authors:  Robert H Knopp; Christine Tsunehara; Barbara M Retzlaff; Brian Fish; Hien Nguyen; Susan Anderson; Thuy Nguyen
Journal:  Metabolism       Date:  2006-12       Impact factor: 8.694

Review 8.  Intestinal failure management at the Cleveland Clinic.

Authors:  Abdullah Shatnawei; Neha R Parekh; Kristen M Rhoda; Rex Speerhas; Judy Stafford; Vijaya Dasari; Cristiano Quintini; Donald F Kirby; Ezra Steiger
Journal:  Arch Surg       Date:  2010-06

9.  Bile Acid malabsorption.

Authors:  Henrik Westergaard
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

10.  Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.

Authors:  Shannon M Rivers; Michael P Kane; Robert S Busch; Gary Bakst; Robert A Hamilton
Journal:  Endocr Pract       Date:  2007 Jan-Feb       Impact factor: 3.443

View more
  25 in total

1.  Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.

Authors:  Matthew McMillin; Gabriel Frampton; Matthew Quinn; Samir Ashfaq; Mario de los Santos; Stephanie Grant; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2015-12-09       Impact factor: 4.307

2.  Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells.

Authors:  Zhenrui Shi; Xuesong Wu; Sebastian Yu; Mindy Huynh; Prasant Kumar Jena; Mimi Nguyen; Yu-Jui Yvonne Wan; Samuel T Hwang
Journal:  J Invest Dermatol       Date:  2020-02-10       Impact factor: 8.551

3.  Polysaccharide-rich red algae (Gelidium amansii) hot-water extracts ameliorate the altered plasma cholesterol and hepatic lipid homeostasis in high-fat diet-fed rats.

Authors:  Shing-Hwa Liu; Hsin-I Hung; Tsung-Han Yang; Chorng-Liang Pan; Meng-Tsan Chiang
Journal:  J Food Drug Anal       Date:  2021-03-15       Impact factor: 6.157

Review 4.  Clinical approach to diarrhea.

Authors:  Roberto Corinaldesi; Vincenzo Stanghellini; Giovanni Barbara; Paola Tomassetti; Roberto De Giorgio
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 5.  The heteromeric organic solute transporter, OSTα-OSTβ/SLC51: a transporter for steroid-derived molecules.

Authors:  Nazzareno Ballatori; Whitney V Christian; Sadie G Wheeler; Christine L Hammond
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 6.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

7.  Treatment of cyanobacterial (microcystin) toxicosis using oral cholestyramine: case report of a dog from Montana.

Authors:  Kelly A Rankin; Karen A Alroy; Raphael M Kudela; Stori C Oates; Michael J Murray; Melissa A Miller
Journal:  Toxins (Basel)       Date:  2013-06       Impact factor: 4.546

8.  Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes.

Authors:  Christel Hero; Sofia Axia Karlsson; Stefan Franzén; Ann-Marie Svensson; Mervete Miftaraj; Soffia Gudbjörnsdottír; Karolina Andersson-Sundell; Björn Eliasson; Katarina Eeg-Olofsson
Journal:  Diabetes Ther       Date:  2021-07-22       Impact factor: 2.945

9.  Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa.

Authors:  Stephen J Genuis; Luke Curtis; Detlef Birkholz
Journal:  ISRN Toxicol       Date:  2013-09-09

Review 10.  Pharmacokinetic drug-drug interaction and their implication in clinical management.

Authors:  Caterina Palleria; Antonello Di Paolo; Chiara Giofrè; Chiara Caglioti; Giacomo Leuzzi; Antonio Siniscalchi; Giovambattista De Sarro; Luca Gallelli
Journal:  J Res Med Sci       Date:  2013-07       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.